March 11, 2017, 1:29 PM|Dr. Jon LaPook introduces us to the next frontier of cancer treatment: Immunotherapy, in which the…
Immunotherapy Post-Surgery Found to Improve Overall Survival for Kidney Cancer
When it comes to kidney cancer treatment, surgery is often the primary option. However, recent studies have shown that combining surgery with immunotherapy can significantly improve overall survival rates for patients.
Immunotherapy is a type of cancer treatment that helps the immune system fight cancer cells more effectively. It works by stimulating the body’s natural defenses to recognize and attack cancer cells.
Unlike traditional cancer treatments like chemotherapy and radiation therapy, which directly target cancer cells, immunotherapy focuses on boosting the immune system’s ability to identify and destroy cancer cells throughout the body.
The Benefits of Immunotherapy Post-Surgery
Recent clinical trials have shown that administering immunotherapy after kidney cancer surgery can lead to improved overall survival rates. This approach helps to eliminate any remaining cancer cells that may have been missed during surgery.
By combining surgery with immunotherapy, doctors can target both the primary tumor and any potential metastases, reducing the risk of cancer recurrence and improving long-term outcomes for patients.
A study published in the Journal of Clinical Oncology found that patients who received immunotherapy after surgery had a significantly higher overall survival rate compared to those who only underwent surgery. The study showed that the addition of immunotherapy reduced the risk of cancer recurrence by up to 30%.
Another study published in the New England Journal of Medicine reported similar findings. The researchers found that patients who received immunotherapy post-surgery had a 42% lower risk of death compared to those who did not receive immunotherapy.
Immunotherapy has emerged as a promising treatment option for kidney cancer patients post-surgery. By harnessing the power of the immune system, this approach can help eliminate residual cancer cells and improve overall survival rates.
As more research is conducted in this field, it is expected that immunotherapy will become an integral part of kidney cancer treatment protocols. Patients should discuss the potential benefits of immunotherapy with their healthcare providers to determine the best course of action for their specific situation.